#FastFacts now available! Reducing risk for cell therapy manufacturing with a battle-tested electroporation platform In this FastFacts, Andrew Mancini demonstrates how #electroporation technology can address key risk factors during the #celltherapy manufacturing process. Watch the video or download the poster to learn about: • How choosing a clinically-validated manufacturing platform for critical steps such as cell electroporation can reduce risk during cell therapy manufacturing • A clinically-validated electroporation platform optimized for cell therapy manufacturing • How to address key risk factors during the cell therapy manufacturing process, such as process variability, complexity, and product yield • The importance of robust, expert technical and regulatory support in enhancing risk mitigation Read the poster or watch the video below:
